Facial vein injection of human cells in severe combined immunodeficiency (SCID) neonatal mice
Intravenous injection is a standard procedure for delivering human stem cells and therapeutic agents. Currently, genetically modified severe combined immunodeficiency (SCID) mice are used for engraftment studies using human cells. SCID neonates have better integration and survivability of human cell...
Main Authors: | Nimshitha Pavathuparambil Abdul Manaph, Mohammed Al-Hawwas, Liang Liu, Donghui Liu, John Hayball, Xin-Fu Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | MethodsX |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2215016118301626 |
Similar Items
-
A direct and non-invasive method for kidney delivery of therapeutics in mice
by: Nimshitha Pavathuparambil Abdul Manaph, et al.
Published: (2018-01-01) -
Urine-derived cells for human cell therapy
by: Nimshitha Pavathuparambil Abdul Manaph, et al.
Published: (2018-07-01) -
Correction to: Urine-derived cells for human cell therapy
by: Nimshitha Pavathuparambil Abdul Manaph, et al.
Published: (2018-08-01) -
Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program
by: Maartje Blom, et al.
Published: (2018-12-01) -
Universal Newborn Screening for Severe Combined Immunodeficiency (SCID)
by: Mirjam van der Burg, et al.
Published: (2019-09-01)